secwatch.observer — SEC 8-K summary
======================================

Issuer:     Enliven Therapeutics, Inc. (ELVN)
CIK:        0001672619
Form:       8-K
Filed at:   2021-10-25T23:59:59+00:00
Accession:  0001564590-21-051756
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Sara Nayeem to resign from IMARA board effective Nov 15, 2021
----------------------------------------------------------------------

- Dr. Sara Nayeem announced resignation from the board of directors on October 21, 2021.
- Resignation effective November 15, 2021, due to a change in her employment.
- No replacement announced; board size will decrease by one member.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1672619/000156459021051756/0001564590-21-051756-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1672619/000156459021051756/imra-8k_20211021.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-051756

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer